PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY
Clinical trials for PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY trials appear
Sign up with your email to follow new studies for PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Simple socks and gloves may shield cancer patients from Chemo's nerve pain
Prevention Not yet recruitingThis study tests whether wearing tight compression garments on hands and feet during chemotherapy can prevent nerve damage (peripheral neuropathy) caused by taxane or oxaliplatin drugs. About 358 breast and colorectal cancer patients will be randomly assigned to wear compression …
Matched conditions: PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY
Phase: NA • Sponsor: Region Jönköping County • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
Fish oil may protect nerves during cancer treatment
Symptom relief Not yet recruitingThis study tests if taking fish oil by mouth can prevent or lessen nerve damage (peripheral neuropathy) caused by the chemotherapy drug bortezomib in people with multiple myeloma. Researchers will compare nerve health in 200 patients who take fish oil versus those who don't. The …
Matched conditions: PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Exercise program aims to ease breast cancer side effects
Symptom relief Not yet recruitingThis study tests a 3-month exercise program for women with breast cancer who have arm swelling (lymphedema) and nerve pain (neuropathy) from treatment. Thirty women will do general and arm-specific exercises twice a week. Researchers will measure changes in arm size and pain leve…
Matched conditions: PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY
Phase: NA • Sponsor: Universitat Internacional de Catalunya • Aim: Symptom relief
Last updated Jun 26, 2026 18:29 UTC